TrialInvestigational new drugs2009

Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336).

Robert P Whitehead et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.